Nanomedicine: Insights from a Bibliometrics-Based Analysis of Emerging Publishing and Research Trends

Abstract

Background and Objectives: Nanomedicine, a term coined by the American engineer Eric Drexler (1955) and Robert Freitas Jr. (1952) in the nineties, can be defined as a complex, multi-disciplinary branch of medicine, in which nano-technologies, molecular biotechnologies, and other nano-sciences are applied at every step of disease management, from diagnosis (nano-diagnostics) to treatment (nano-therapeutics), prognosis, and monitoring of biological parameters and biomarkers. Nanomedicine is a relatively young discipline, which is increasingly and exponentially growing, characterized by emerging ethical issues and implications. Nanomedicine has branched out in hundreds of different sub-fields. Materials and Methods: A bibliometrics-based analysis was applied mining the entire content of PubMed/MEDLINE, using “nanomedicine” as a Medical Subject Heading (MeSH) search term. Results: A sample of 6696 articles were extracted from PubMed/MEDLINE and analyzed. Articles had been published in the period from 2003 to 2019, showing an increasing trend throughout the time. Six thematic clusters emerged (first cluster: molecular methods; second cluster: molecular biology and nano-characterization; third cluster: nano-diagnostics and nano-theranostics; fourth cluster: clinical applications, in the sub-fields of nano-oncology, nano-immunology and nano-vaccinology; fifth cluster: clinical applications, in the sub-fields of nano-oncology and nano-infectiology; and sixth cluster: nanodrugs). The countries with the highest percentages of articles in the field of nanomedicine were the North America (38.3%) and Europe (35.1%). Conclusions: The present study showed that there is an increasing trend in publishing and performing research in the super-specialty of nanomedicine. Most productive countries were the USA and European countries, with China as an emerging region. Hot topics in the last years were nano-diagnostics and nano-theranostics and clinical applications in the sub-fields of nano-oncology and nano-infectiology.

Manufacturing of 3D-Printed Microfluidic Devices for the Synthesis of Drug-Loaded Liposomal Formulations

“…Over the past two decades, nanotechnologies have progressed steadily, resulting in structures, devices, and systems with innovative properties and functions. The application of nanotechnologies to human health led to promising results in branches of medicine concerning cancer and neurological, cardiovascular, and infectious diseases, with positive results also for the development of antiviral vaccines [ 1 , 2 ]. Moreover, several promising small molecule drugs and genes with issues of stability, solubility, and nonspecific toxicity can now be delivered using nanocarriers such as micelles, polymeric or liposomal formulations, and nanoemulsions [ 3 , 4 ].…”

COVID-19 Pandemic Related Research in Africa: Bibliometric Analysis of Scholarly Output, Collaborations and Scientific Leadership

“…It enables scholars to assess and visualize emerging research trends and hot-spots in the scientific literature from a quantitative standpoint. Moreover, scientometrics allows a rigorous analysis of patterns in terms of article usage and citations, generating an extensive series of measurements and indicators that can provide policy- and decision-makers with useful information concerning the effectiveness of their policies [ 1 , 2 , 3 ].…”

Nanomedicine Research in India: A Bibliometric Assessment of Publications Output during 2002-20

“…The study evaluated India's innovations on the basis of five indicators: financial ecosystem, technology source, research translation, bibliographic data (patents and publications 2010-15). Bragazzi 8 studied a total of 6696 global articles published during 2003-19 on nanomedicine. The publications data was sourced from PubMed/MEDLINE database The author identified six thematic clusters (first cluster: molecular methods; second cluster: molecular biology and nano-characterization; third cluster: nano-diagnostics and nano-theranostics; fourth cluster: clinical applications, in the sub-fields of nano-oncology, nano-immunology and nano-vaccinology; fifth cluster: clinical applications, in the sub-fields of nano-oncology and nano-infectiology; and sixth cluster: nanodrugs).…”